SUPERNUS PHARMACEUTICALS, INC. Goodwill, Acquired During Period
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Goodwill, Acquired During Period of $7.86 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2026-03-02
- SUPERNUS PHARMACEUTICALS, INC. goodwill, acquired during period for the quarter ending 2025-12-31 was $5.80M.
- SUPERNUS PHARMACEUTICALS, INC. goodwill, acquired during period for fiscal 2025 was $7.86M.
- SUPERNUS PHARMACEUTICALS, INC. goodwill, acquired during period for fiscal 2024 was $0.00.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|
| 2025-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $7.86M 10-K · filed 2026-03-02 | |
| 2025-09-30 | $2.06M 10-Q · filed 2025-11-06 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |